Clinical trial suggests fecal transplants may protect transplant patients against multi-drug-resistant organisms

日本 ニュース ニュース

Clinical trial suggests fecal transplants may protect transplant patients against multi-drug-resistant organisms
日本 最新ニュース,日本 見出し
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

A team of infectious disease researchers at the Emory University School of Medicine, working with colleagues from the Georgia Institute of Technology, has found via clinical trial that fecal transplants after kidney transplantation reduce the susceptibility of patients to infections by multi-drug-resistant organisms (MDROs).

retrieved 2 November 2023 from https://medicalxpress.com/news/2023-11-clinical-trial-fecal-transplants-transplant.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Teenagers are most likely to seek help for anxiety or depression at the start of the school year, finds studyMar 19, 2023Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

medical_xpress /  🏆 101. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Clinical trial suggests ALS drug effective for treating spinal cord injuriesClinical trial suggests ALS drug effective for treating spinal cord injuriesA small clinical trial with a pharmacokinetic sub-study, led by a pharmacologist at the University of Houston, has demonstrated the promising effectiveness of the drug Riluzole for improving functionality in people with acute spinal cord injuries (SCI) if the drug is taken within 12 hours post-injury.
続きを読む »

Clinical trial demonstrates the effectiveness of ALS drug in treating people with acute spinal cord injuriesClinical trial demonstrates the effectiveness of ALS drug in treating people with acute spinal cord injuriesA small clinical trial with a pharmacokinetic sub-study, led by a world-renowned pharmacologist at the University of Houston, has demonstrated the promising effectiveness of the drug Riluzole for improving functionality in people with acute spinal cord injuries (SCI) if the drug is taken within 12 hours post-injury.
続きを読む »

Advances in grain research illuminate potential for precision nutrition in clinical settingsAdvances in grain research illuminate potential for precision nutrition in clinical settingsGrains are a primary source of energy (calories) in the diet.
続きを読む »

PacBio announces HiFi Solves, a global consortium of clinical genomics research leadersPacBio announces HiFi Solves, a global consortium of clinical genomics research leadersPacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the creation of the HiFi Solves consortium.
続きを読む »

Clinical intervention directed at social risks does not increase experiences of discrimination, finds studyClinical intervention directed at social risks does not increase experiences of discrimination, finds studyA growing recognition of the health impact of social risks—such as food insecurity and homelessness—has prompted researchers, health care providers and policymakers to consider ways to address these risk factors as part of holistic clinical care.
続きを読む »



Render Time: 2025-04-04 22:23:30